Developer docs
API playgroundTry for free, no card

Search company profiles

BAG Holding

Full company profile

uuid003y3mj

Namestring
BAG Holding
Legal namestring
BAG Holding GmbH
Websiteurl
bag-group.com
Company typeenum
Private
Founded yearint
1947
Descriptiontext

BAG Holding GmbH is a German family-owned medical technology holding headquartered in Lich, Hesse, founded in 1947 by Gotthard Sachsenberg and now managed in the third generation by Dr. med. Nicolas Sachsenberg. The group operates through two wholly-owned subsidiaries: BAG Diagnostics GmbH, which develops and sells in vitro diagnostic test systems and reagents for safe blood transfusion and transplantation compatibility (including the 'Mr. Spot' fully automated SSO-based molecular genetic analysis system launched in 2009, HLA typing since 1990, nucleic acid diagnostics since 1996, and biochemical bacteria and fungi detection since 1972); and BAG Health Care GmbH, which operates as a GMP pharmaceutical contract manufacturer specializing in sterile injectables (parenterals) and freeze-dried products (lyophilisates), with freeze-drying capacity quadrupled during 2004-2008.

The group addresses two distinct end markets. For diagnostics, BAG serves hospital laboratories, blood banks, and transplantation centers, where its products support HLA typing for organ and stem cell transplants and screening for transfusion-transmitted infections. For pharmaceutical manufacturing, BAG Health Care serves pharmaceutical companies requiring outsourced sterile drug production capacity. Distribution is direct enterprise sales in both segments, with no third-party resellers disclosed. Approximately 65% of revenue is exported, indicating a global customer footprint rather than a primarily domestic operation, and the corporate site emphasizes 'at home in Lich, present in the world'.

The revenue model is a hybrid of product sales (diagnostic kits, instruments, and reagents) and contract-manufacturing services (parenterals and lyophilisates produced to client specifications). Pricing is not publicly disclosed and is understood to be negotiated contract-by-contract, consistent with B2B pharmaceutical and diagnostic procurement. The group is privately held with no public listing; Hannover Finanz has been the long-term private equity partner since 1989. In 2019, the legacy operating company was reorganized into the current holding-plus-two-operating-units structure. Marketing relies on three corporate websites, a LinkedIn corporate presence, and a dedicated employer-branding job portal rather than third-party channel partners.

Short descriptiontext

BAG Holding GmbH is a German family-owned medical technology holding founded in 1947 and now in its third generation, operating BAG Diagnostics (transfusion and transplantation diagnostic test systems and reagents, including the Mr. Spot automated molecular genetic analyzer) and BAG Health Care (pharmaceutical contract manufacturing of sterile parenterals and lyophilisates), serving global healthcare institutions and pharmaceutical companies with ~65% of revenue from exports.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLich, Germany
HQ citystring
Lich
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
In vitro diagnostics, Pharmaceutical contract manufacturing, HLA typing, Sterile injectables, Transfusion diagnostics
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
In Vitro Diagnostics & Pharmaceutical Contract Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Diagnostic Products and Reagents
TypeHardware Sales
Description

BAG Diagnostics develops and sells test systems and reagents for safe transfusion and transplantation diagnostics, including molecular genetic analysis systems and biochemical detection products.

bag-group.com
2Pharmaceutical Contract Manufacturing
TypeProfessional Services
Description

BAG Health Care operates as a pharmaceutical contract manufacturer specializing in production of parenterals (injectable drugs) and lyophilisates (freeze-dried products) for pharmaceutical companies.

bag-group.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1BAG Diagnostics
Description

Develops test systems and reagents for safe transfusion and transplantation diagnostics

bag-group.com
+1 more record
Core offering1 text field

BAG Holding GmbH is a family-owned medical technology group operating through two divisions: BAG Diagnostics develops and sells test systems and reagents for safe transfusion and transplantation diagnostics (including HLA typing, molecular genetic analysis systems, and biochemical detection products), while BAG Health Care is a pharmaceutical contract manufacturer specializing in the production of sterile parenterals (injectable drugs) and lyophilisates (freeze-dried products) for pharmaceutical companies worldwide.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

BAG Holding GmbH is a family-owned medical technology group founded in 1947, operating as a holding company with two main business divisions: BAG Diagnostics and BAG Health Care. BAG Diagnostics specializes in in vitro diagnostic products including test systems, reagents, and the Mr. Spot automated molecular genetic analysis system for transfusion and transplantation diagnostics. BAG Health Care operates as a pharmaceutical contract manufacturer producing sterile injectables and lyophilizates. The group serves customers worldwide with approximately 65% export quota and has been developing medical solutions for over 75 years.

Product and service5 records
1Mr. Spot
CategoryMolecular Genetic Analysis Instrument
Description

A fully automated Sequence-Specific Oligonucleotide (SSO) based molecular genetic analysis system for HLA typing and genetic diagnostics, designed for hospital laboratories and clinical diagnostics.

2HLA Products
CategoryTransplantation Diagnostics
Description

HLA (Human Leukocyte Antigen) products manufactured since 1990 for transplantation diagnostics, used for matching donors and recipients in organ and stem cell transplantation.

3Nucleic Acid Diagnostics
CategoryMolecular Diagnostics
Description

Nucleic acid-based diagnostic products for molecular testing, used by hospital laboratories and clinical diagnostics facilities for genetic material detection.

4Biochemical Detection Products (API Diagnostic System)
CategoryMicrobiology Diagnostics
Description

Biochemical diagnostic system for bacterial and fungal identification, used in microbiology laboratories for pathogen detection.

5Culture Media Quality Control
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Recipharm
TypeDirect peer
Description

European CDMO offering sterile fill-finish, lyophilization, and parenteral manufacturing services to pharma companies — closely aligned with BAG Health Care's service offering.

TypeEmerging player
Description

Molecular diagnostics and sample-preparation technologies company with overlap to BAG Diagnostics' nucleic acid diagnostics and SSO-based molecular testing offerings (Mr. Spot platform).

TypeDirect peer
Description

Global diagnostics company with significant blood-typing and HLA/immunohematology reagent lines serving hospitals and blood banks, comparable to BAG Diagnostics' transfusion/transplantation focus.

TypeDirect peer
Description

Specialist in transfusion and transplantation diagnostics, offering reagents and instruments for blood typing, antibody screening, and molecular HLA typing — directly overlapping BAG Diagnostics' core transfusion/transplantation portfolio.

TypeDirect peer
Description

German-headquartered CDMO with solid dosage forms, sterile liquids, and lyophilization capabilities serving pharmaceutical companies — a regional direct peer to BAG Health Care's parenterals business.

TypeDirect peer
Description

Focused on transfusion diagnostics, offering a broad transfusion medicine portfolio including serological reagent lines and a MosaiQ molecular platform — a near-direct competitor to BAG Diagnostics.

TypeDirect peer
Description

Swiss CDMO specializing in sterile fill-finish of injectables and APIs, including lyophilized products — a closely comparable pharmaceutical contract manufacturer to BAG Health Care.

TypeBroad incumbent
Description

World's largest CDMO offering biologics, small molecules, and parenteral fill-finish at global scale; competes with BAG Health Care in sterile injectables/lyophilization but with substantially broader capabilities.

TypeDirect peer
Description

Global CDMO with strong capabilities in sterile injectable and lyophilized drug manufacturing, directly comparable to BAG Health Care's parenteral and lyophilisate contract manufacturing services.

TypeBroad incumbent
Description

Diversified life sciences giant with diagnostics instruments/reagents (including transplant/transfusion-adjacent offerings) and pharmaceutical services, providing broad incumbent competition across both BAG business units.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BAG Holding

In Vitro Diagnostics & Pharmaceutical Contract Manufacturingbag-group.com

BAG Holding GmbH is a German family-owned medical technology holding founded in 1947 and now in its third generation, operating BAG Diagnostics (transfusion and transplantation diagnostic test systems and reagents, including the Mr. Spot automated molecular genetic analyzer) and BAG Health Care (pharmaceutical contract manufacturing of sterile parenterals and lyophilisates), serving global healthcare institutions and pharmaceutical companies with ~65% of revenue from exports.

What BAG Holding does

BAG Holding GmbH is a German family-owned medical technology holding headquartered in Lich, Hesse, founded in 1947 by Gotthard Sachsenberg and now managed in the third generation by Dr. med. Nicolas Sachsenberg. The group operates through two wholly-owned subsidiaries: BAG Diagnostics GmbH, which develops and sells in vitro diagnostic test systems and reagents for safe blood transfusion and transplantation compatibility (including the 'Mr. Spot' fully automated SSO-based molecular genetic analysis system launched in 2009, HLA typing since 1990, nucleic acid diagnostics since 1996, and biochemical bacteria and fungi detection since 1972); and BAG Health Care GmbH, which operates as a GMP pharmaceutical contract manufacturer specializing in sterile injectables (parenterals) and freeze-dried products (lyophilisates), with freeze-drying capacity quadrupled during 2004-2008.

The group addresses two distinct end markets. For diagnostics, BAG serves hospital laboratories, blood banks, and transplantation centers, where its products support HLA typing for organ and stem cell transplants and screening for transfusion-transmitted infections. For pharmaceutical manufacturing, BAG Health Care serves pharmaceutical companies requiring outsourced sterile drug production capacity. Distribution is direct enterprise sales in both segments, with no third-party resellers disclosed. Approximately 65% of revenue is exported, indicating a global customer footprint rather than a primarily domestic operation, and the corporate site emphasizes 'at home in Lich, present in the world'.

The revenue model is a hybrid of product sales (diagnostic kits, instruments, and reagents) and contract-manufacturing services (parenterals and lyophilisates produced to client specifications). Pricing is not publicly disclosed and is understood to be negotiated contract-by-contract, consistent with B2B pharmaceutical and diagnostic procurement. The group is privately held with no public listing; Hannover Finanz has been the long-term private equity partner since 1989. In 2019, the legacy operating company was reorganized into the current holding-plus-two-operating-units structure. Marketing relies on three corporate websites, a LinkedIn corporate presence, and a dedicated employer-branding job portal rather than third-party channel partners.

BAG Holding firmographics

Firmographics
Name
BAG Holding
Legal name
BAG Holding GmbH
Website
https://bag-group.com
Company type
Private
Founded year
1947
Operating status
Operating
Headcount range
1–10 employees
Short description
BAG Holding GmbH is a German family-owned medical technology holding founded in 1947 and now in its third generation, operating BAG Diagnostics (transfusion and transplantation diagnostic test systems and reagents, including the Mr. Spot automated molecular genetic analyzer) and BAG Health Care (pharmaceutical contract manufacturing of sterile parenterals and lyophilisates), serving global healthcare institutions and pharmaceutical companies with ~65% of revenue from exports.
Ownership category
akta.pro rank

Where BAG Holding is headquartered

Location

Headquarters

HQ city
Lich
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

BAG Holding business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Diagnostic Products and Reagents: BAG Diagnostics develops and sells test systems and reagents for safe transfusion and transplantation diagnostics, including molecular genetic analysis systems and biochemical detection products.
  2. Pharmaceutical Contract Manufacturing: BAG Health Care operates as a pharmaceutical contract manufacturer specializing in production of parenterals (injectable drugs) and lyophilisates (freeze-dried products) for pharmaceutical companies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

BAG Holding product offering

Product offering

Core offering

BAG Holding GmbH is a family-owned medical technology group operating through two divisions: BAG Diagnostics develops and sells test systems and reagents for safe transfusion and transplantation diagnostics (including HLA typing, molecular genetic analysis systems, and biochemical detection products), while BAG Health Care is a pharmaceutical contract manufacturer specializing in the production of sterile parenterals (injectable drugs) and lyophilisates (freeze-dried products) for pharmaceutical companies worldwide.

Product overview

BAG Holding GmbH is a family-owned medical technology group founded in 1947, operating as a holding company with two main business divisions: BAG Diagnostics and BAG Health Care. BAG Diagnostics specializes in in vitro diagnostic products including test systems, reagents, and the Mr. Spot automated molecular genetic analysis system for transfusion and transplantation diagnostics. BAG Health Care operates as a pharmaceutical contract manufacturer producing sterile injectables and lyophilizates. The group serves customers worldwide with approximately 65% export quota and has been developing medical solutions for over 75 years.

Differentiator

Problem solved

Functional benefit

Brands

  • BAG Diagnostics: Develops test systems and reagents for safe transfusion and transplantation diagnostics
  • BAG Health Care

Products and services

  • Mr. Spot A fully automated Sequence-Specific Oligonucleotide (SSO) based molecular genetic analysis system for HLA typing and genetic diagnostics, designed for hospital laboratories and clinical diagnostics.
  • HLA Products HLA (Human Leukocyte Antigen) products manufactured since 1990 for transplantation diagnostics, used for matching donors and recipients in organ and stem cell transplantation.
  • Nucleic Acid Diagnostics Nucleic acid-based diagnostic products for molecular testing, used by hospital laboratories and clinical diagnostics facilities for genetic material detection.
  • Biochemical Detection Products (API Diagnostic System) Biochemical diagnostic system for bacterial and fungal identification, used in microbiology laboratories for pathogen detection.
  • Culture Media Quality Control

Companies that use BAG Holding

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

BAG Holding technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

BAG Holding partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

BAG Holding competitors and assessment

Company assessment

Direct peers

  • Recipharm: European CDMO offering sterile fill-finish, lyophilization, and parenteral manufacturing services to pharma companies — closely aligned with BAG Health Care's service offering.
  • Bio-Rad Laboratories: Global diagnostics company with significant blood-typing and HLA/immunohematology reagent lines serving hospitals and blood banks, comparable to BAG Diagnostics' transfusion/transplantation focus.
  • Immucor: Specialist in transfusion and transplantation diagnostics, offering reagents and instruments for blood typing, antibody screening, and molecular HLA typing — directly overlapping BAG Diagnostics' core transfusion/transplantation portfolio.
  • Aenova Group: German-headquartered CDMO with solid dosage forms, sterile liquids, and lyophilization capabilities serving pharmaceutical companies — a regional direct peer to BAG Health Care's parenterals business.
  • Quotient Limited: Focused on transfusion diagnostics, offering a broad transfusion medicine portfolio including serological reagent lines and a MosaiQ molecular platform — a near-direct competitor to BAG Diagnostics.
  • Siegfried Holding: Swiss CDMO specializing in sterile fill-finish of injectables and APIs, including lyophilized products — a closely comparable pharmaceutical contract manufacturer to BAG Health Care.
  • Catalent: Global CDMO with strong capabilities in sterile injectable and lyophilized drug manufacturing, directly comparable to BAG Health Care's parenteral and lyophilisate contract manufacturing services.

Emerging players

  • QIAGEN: Molecular diagnostics and sample-preparation technologies company with overlap to BAG Diagnostics' nucleic acid diagnostics and SSO-based molecular testing offerings (Mr. Spot platform).

Broad incumbents

  • Lonza Group: World's largest CDMO offering biologics, small molecules, and parenteral fill-finish at global scale; competes with BAG Health Care in sterile injectables/lyophilization but with substantially broader capabilities.
  • Thermo Fisher Scientific: Diversified life sciences giant with diagnostics instruments/reagents (including transplant/transfusion-adjacent offerings) and pharmaceutical services, providing broad incumbent competition across both BAG business units.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

BAG Holding social profiles

Digital presence

BAG Holding financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BAG Holding leadership team

Management profile

Number of profiles

Profiles2 records

BAG Holding subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

BAG Holding funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BAG Holding M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BAG Holding

What does BAG Holding do?

BAG Holding GmbH is a family-owned medical technology group operating through two divisions: BAG Diagnostics develops and sells test systems and reagents for safe transfusion and transplantation diagnostics (including HLA typing, molecular genetic analysis systems, and biochemical detection products), while BAG Health Care is a pharmaceutical contract manufacturer specializing in the production of sterile parenterals (injectable drugs) and lyophilisates (freeze-dried products) for pharmaceutical companies worldwide.

Is BAG Holding a public or private company?

BAG Holding is a private company. It is classified as family owned and is currently operating.

When was BAG Holding founded?

BAG Holding was founded in 1947. It employs 1 to 10 people.

Where is BAG Holding based?

BAG Holding is headquartered in Lich, Germany, in the Europe region.

How does BAG Holding make money?

Two revenue lines are on record. Diagnostic Products and Reagents are the primary driver. The others are pharmaceutical Contract Manufacturing.

Who are BAG Holding's main competitors?

Direct peers on record are Recipharm, Bio-Rad Laboratories, Immucor, Aenova Group, Quotient Limited, Siegfried Holding and Catalent. QIAGEN is listed as an emerging player. Broad incumbents are Lonza Group and Thermo Fisher Scientific.

Does BAG Holding have an API?

No public API is recorded for BAG Holding.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales